Cardiovascular Regenerative Medicine
Cardiovascular regenerative medicine focuses on repairing and regenerating damaged heart and vascular tissues to address the growing global burden of cardiovascular diseases, including heart failure, myocardial infarction, and vascular disorders. This session will explore the latest advances in cardiac tissue engineering, vascular regeneration, and stem cell–based therapies designed to restore normal cardiovascular function. Participants will gain insights into the use of mesenchymal stem cells, cardiac progenitor cells, induced pluripotent stem cells (iPSCs), and bioengineered grafts for repairing heart muscle and blood vessels. The session will also highlight innovations in biomaterial scaffolds, extracellular matrix–based therapies, and growth factor delivery systems that support cardiac repair and angiogenesis. Emerging technologies such as engineered heart tissues, 3D bioprinted cardiac patches, organ-on-chip cardiovascular models, and gene editing approaches for heart disease treatment will also be discussed. Key challenges including tissue integration, electrical conductivity, vascularization, immune response, and long-term functionality will be addressed. Translational aspects such as clinical trials, regulatory pathways, and scalability of cardiovascular therapies will also be emphasized. By bringing together cardiologists, biomedical researchers, bioengineers, and industry professionals, this session aims to accelerate innovation and collaboration in developing next-generation regenerative solutions that can reduce mortality and improve outcomes in cardiovascular disease patients worldwide.